SenesTech Inc. (NASDAQ: SNES) Begins Taking Orders for

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
227
SenesTech Inc. (NASDAQ: SNES) Begins Taking Orders for their new Soft Bait Rodent Contraceptive That Provides Unique Approach to Pest Control

- Arizona-based SenesTech Inc. provides a unique approach to rodent pest control by formulating a contraceptive that works as birth control in both male and female rats
- A major milestone has been reached by the company as it recently began taking orders for its new Evolve(TM) Soft Bait formulation, which joins SenesTech’s liquid ContraPest(R) brand as a population-control solution that avoids some of the problems associated with lethal rodenticides
- The Evolve(TM) Soft Bait product is targeting the vast professional pest control market that prefers a non-liquid product, as well as providing a consumer-friendly option that may be marketed through big box retailers and e-commerce providers
- SenesTech’s operation has been growing rapidly this year, and company officers stated last month that its “pro forma cash balance” is $4 million with no long-term debt

With the advent of cooler weather in the Northern Hemisphere, rodents become more noticeable in homes and buildings as they seek warmer refuge. Pest control giant Orkin estimates mice and other rodents invade around 21 million homes across the United States each fall, according to its annual report on the “50 rattiest cities” (https://nnw.fm/rgLWP ).

Rodent control innovator SenesTech (NASDAQ: SNES) is using its own unique approach to the science of reducing rat populations to help clients and pest control companies enjoy the holiday season without such unwanted guests. They have developed a means of birth control for the rodents that keeps their populations from growing, allowing their numbers to dwindle generationally.

“The existing lethal solutions’in the marketplace are limited by rats’ reproduction rates, resistance and aversion, as well as the enhanced social and political limitations on the use of poison,” SenesTech CEO and President Joel Fruendt said during a webcast interview last month at the Lytham Partners Fall 2023 Investor Conference (https://nnw.fm/ur57a ).

The company is building on its initial successes with its trademarked liquid ContraPest(R) bait by recently introducing companion brand Evolve(TM) Soft Bait, which gives SenesTech a non-liquid formulation for its portfolio. Non-liquid solutions make up 90 to 95 percent of the rodent control market and are preferred by professional exterminators, according to Fruendt, so the Evolve bait presents the company with the possibility of exponential revenue growth.

“We’ve experienced rapid growth over the past few years,” CFO Tom Chesterman said during the Lytham webcast. “Most recent trends confirm that growth is accelerating as our initiatives put place in the first half of the year take hold. … At the end of June, we had $2.2 million in cash but in August we closed on a warrant exercise, which brought in an additional $2.1 million gross proceeds. Netted expenses, our pro forma cash balance, would be $4 million.”

Evolve is highly palatable to rats, easy to deploy, and can be placed in a wide variety of environments including municipal buildings, parks, recreation facilities, sports venues, food processing facilities, correctional facilities, subways, medical facilities, agribusiness, zoos and residential locations, the company stated in a news release announcing the soft bait’s availability (https://nnw.fm/iNwBS ).

The company recommends placing the contraceptive bait in tamper-resistant stations to limit exposure for non-targeted species, but adds that the low levels of the active ingredient are specifically suited to rats’ body masses and larger mammals would only see effects if they repeatedly ingest a substantial amount over several weeks, while small birds appear more tolerant of it because of their distinct digestive systems.

“Evolve’s active ingredient, gossypol, derived from cottonseed, has a well-documented record of efficacy, and was developed under the EPA’s minimum risk rules, also known as ’25B'”, CTO Dan Palasky stated in the news release. “We will be publishing a white paper summarizing this data, as well as continuing to perform our own field tests.”

Previous field tests using the liquid ContraPest formulation targeted West Coast and East Coast poultry farms. Rat populations were evaluated monthly over the course of a year, and the company found that in the West Coast study ContraPest cut the rat population in half in three months and produced a sustained 90 percent reduction over the 12-month study. In the East Coast study, the client reported an 88 percent improvement in the survival of the baby chicks after reducing the rat population with ContraPest.

Fruendt said the East Coast client projected $600,000 in increased revenue as a result of using ContraPest, following on an investment of $10,000 to incorporate ContraPest into its pest management program, marking a significant ROI.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://nnw.fm/SNES

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer


SenesTech Inc. (SNES) Stock Research Links

SNES Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading

Top 5 Most Recently Viewed Articles

Hawaiian Holdings Achieves Remarkable Stock Milestone

Updated Category News Views 54

Hawaiian Holdings Stock Hits New High In an impressive show of resilience, Hawaiian Holdings Inc. (NASDAQ: HA) has reached a remarkable 52-week high of $17.76. This achievement marks a significant rebound for the airline, reflecting a stock price that has more than doubled in the past year with a striking 124.97% increase. This week's peak indicates growing investor...

Continue Reading
Zebra Technologies Enhances Brand Engagement with PR Agency

Updated Category News Views 208

Zebra Technologies Partners with Ruder Finn to Boost Brand Presence Zebra Technologies Corporation, a frontrunner in digitizing and automating frontline workflows, has enlisted Ruder Finn as its public relations Agency of Record for the Americas. This strategic collaboration aims to elevate Zebra’s brand visibility while highlighting its transformative impact on...

Continue Reading
Infortar Expands Portfolio with Full Ownership of Subsidiary

Updated Category News Views 163

Infortar Strengthens Its Position in Real Estate Aktsiaselts Infortar has recently made a strategic move by acquiring a full ownership stake in OÜ INF Saue. This acquisition allows Infortar to consolidate its real estate operations, further broadening its scope and reach in the market. OÜ INF Saue was previously partially owned, with Infortar purchasing the remaining...

Continue Reading
Class Action Lawsuit Filed Against AppLovin Corporation Over Fraud Claims

Updated Category News Views 169

Class Action Lawsuit Filed Against AppLovin Corporation Pomerantz LLP has announced a significant class action lawsuit against AppLovin Corporation (NASDAQ: APP), focusing on serious allegations pertaining to securities fraud. Investors are encouraged to reach out to legal representatives if they have experienced financial losses due to their investments in AppLovin....

Continue Reading
Immunic, Inc. Experiences Market Trials Amidst Stock Low

Updated Category News Views 130

Stock Performance Overview Immunic, Inc. (NASDAQ: IMUX) has encountered turbulence in a competitive market, with its stock price dropping to a 52-week low of $0.97. This decline indicates a notable decrease in value compared to previous assessments, with a year-to-date change of -18.07%. Despite this downturn, the company holds a robust liquidity position, characterized...

Continue Reading